ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

South Carolina Clinic and Anil Potti Part Ways

February 24, 2012

NRSAs Renamed For Kirschstein.

June 21, 2002

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008